Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Anti-HIV drugs save vision, improve outlook for AIDS patients

14.05.2003


A new study from Johns Hopkins researchers shows the multiple anti-HIV drug regimen called highly active antiretroviral therapy (HAART) saves eyesight as well as lives. A second study led by Johns Hopkins researchers finds that among AIDS patients with longstanding vision problems, those who took HAART reported higher overall quality of life.



The Johns Hopkins team reported in the April issue of Archives of Ophthalmology that AIDS patients who received HAART had a 75 percent lower risk of visual impairment than those who did not. In the second, multicenter study, published in the May issue of the journal Ophthalmology, AIDS patients with vision loss reported a lower vision-related quality of life, although those who took HAART reported higher overall quality of life than those who did not.

AIDS patients are at high risk of vision loss from cytomegalovirus (CMV) retinitis, an infectious disease of the retina. Symptoms include "floaters" and permanent loss of central vision. With HAART, which became available in 1995, many patients’ immune systems seem to recover enough to control CMV retinitis. The condition at one time affected 30 percent of patients at some point during their lives, but has probably decreased to 7.5 percent with the advent of HAART, says John H. Kempen, M.D., Ph.D., lead author of both studies and assistant professor of ophthalmology and epidemiology. By the time CMV is diagnosed, Kempen says, many AIDS patients are already legally blind or have significant vision loss.


"AIDS patients should take HAART as soon as and as much as they can," he says. "HAART often can save both their life and their vision."

In the Archives study, Kempen and his team evaluated 648 AIDS patients seen at the Wilmer Eye Institute at Johns Hopkins between August 1983 and March 2000. Seventeen percent had 20/200 vision (the definition of legal blindness) at the time of diagnosis, while 33 percent had 20/50 vision -- poor enough to restrict their ability to drive. Whites were less likely to have visual impairment, while injection drug users had a higher prevalence of visual impairment. Patients were followed monthly for disease progression.

One year later, 42 percent of 426 patients lost visual acuity equivalent to three lines on the vision chart, 30 percent lost the equivalent of six lines on the chart and 23 percent lost the equivalent of 10 lines on the chart. By one year after CMV retinitis diagnosis, the incidence of vision loss to the level of 20/50 vision was 34 percent and the incidence of vision loss to the level of 20/200 vision was 24 percent. Thus, within the first year after being diagnosed with CMV retinitis, over half (56 percent) had vision loss to the level of 20/50, and about a third (37 percent) were legally blind.

Ninety-three patients (126 eyes) received HAART during the study’s follow-up. Of these, 46 patients (64 eyes) had substantial improvement in their immunity, while 47 (62 eyes) did not. Those who received HAART had a much lower incidence of visual acuity loss compared with patients who did not receive the therapy, especially those who had improvement of their immunity.

In the second study, a report from the Longitudinal Study of Ocular Complications of AIDS, researchers at Johns Hopkins and 18 other centers across the country questioned 971 AIDS patients ages 13 and up about their quality of life related to vision and overall health. Patients were enrolled between September 1998 and March 2001. Fifty patients had newly diagnosed CMV retinitis, 212 patients had longstanding CMV retinitis of an average three years’ duration, and 709 patients had no CMV retinitis. Newly diagnosed patients tended to be female, younger and African-American. They were more likely to have detectable CMV DNA in their blood and had been diagnosed with AIDS more recently, so were less likely to be taking HAART.

The longstanding and newly diagnosed CMV retinitis groups scored substantially worse in vision-related quality of life than the group without CMV retinitis. However, general health-related quality of life scores for the longstanding CMV retinitis group tended to be similar to, or better than, those for patients without CMV retinitis, mostly due to the effects of HAART. Patients with newly diagnosed CMV retinitis tended to score worse on the general health-related quality of life scale.



The risk of vision loss study was supported by the National Eye Institute. Co-authors were Douglas A. Jabs, M.D., M.B.A.; Laura A. Wilson, M.Sc.; James P. Dunn, M.D.; Sheila K. West, Ph.D.; and James A. Tonascia, Ph.D.

The quality of life study also was supported by the National Eye Institute, as well as the National Center for Research Resources. Co-authors were Barbara K. Martin, Ph.D.; Albert W. Wu, M.D., M.P.H.; Bruce Barron, M.D.; Jennifer E. Thorne, M.D.; and Douglas A. Jabs, M.D., M.B.A.

Kempen, J.H. et al, "Risk of Vision Loss in Patients with Cytomegalovirus Retinitis and the Acquired Immunodeficiency Syndrome," Archives of Ophthalmology, April 2003; Vol. 121: pages 466-476.

Kempen, J.H. et al, "The Effect of Cytomegalovirus Retinitis on the Quality of Life of Patients with the Acquired Immune Deficiency Syndrome in the Era of Highly Active Anti-retroviral Therapy," Ophthalmology, May 2003.

Karen Blum | EurekAlert!
Further information:
http://www.wilmer.jhu.edu
http://archopht.ama-assn.org/
http://www.nei.nih.gov

More articles from Health and Medicine:

nachricht Millions through license revenues
27.04.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht New High-Performance Center Translational Medical Engineering
26.04.2017 | Fraunhofer ITEM

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Making lightweight construction suitable for series production

More and more automobile companies are focusing on body parts made of carbon fiber reinforced plastics (CFRP). However, manufacturing and repair costs must be further reduced in order to make CFRP more economical in use. Together with the Volkswagen AG and five other partners in the project HolQueSt 3D, the Laser Zentrum Hannover e.V. (LZH) has developed laser processes for the automatic trimming, drilling and repair of three-dimensional components.

Automated manufacturing processes are the basis for ultimately establishing the series production of CFRP components. In the project HolQueSt 3D, the LZH has...

Im Focus: Wonder material? Novel nanotube structure strengthens thin films for flexible electronics

Reflecting the structure of composites found in nature and the ancient world, researchers at the University of Illinois at Urbana-Champaign have synthesized thin carbon nanotube (CNT) textiles that exhibit both high electrical conductivity and a level of toughness that is about fifty times higher than copper films, currently used in electronics.

"The structural robustness of thin metal films has significant importance for the reliable operation of smart skin and flexible electronics including...

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Fighting drug resistant tuberculosis – InfectoGnostics meets MYCO-NET² partners in Peru

28.04.2017 | Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

 
Latest News

Wireless power can drive tiny electronic devices in the GI tract

28.04.2017 | Medical Engineering

Ice cave in Transylvania yields window into region's past

28.04.2017 | Earth Sciences

Nose2Brain – Better Therapy for Multiple Sclerosis

28.04.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>